Cloning and characterization of Exodus, a novel β-chemokine

Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue. Some chemokines such as MIP-1 alpha also inhibit hematopoietic progenitor cell proliferation. Recently, three chemokines, MIP-1 alpha, MIP-1 beta, and RANTES, have been found to significantly decre...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 89; no. 9; pp. 3315 - 3322
Main Authors HROMAS, R, GRAY, P. W, COOPER, S, BROXMEYER, H. E, KLEMSZ, M. J, CHANTRY, D, GODISKA, R, KRATHWOHL, M, FIFE, K, BELL, G. I, TAKEDA, J, ARONICA, S, GORDON, M
Format Journal Article
LanguageEnglish
Published Washington, DC The Americain Society of Hematology 01.05.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue. Some chemokines such as MIP-1 alpha also inhibit hematopoietic progenitor cell proliferation. Recently, three chemokines, MIP-1 alpha, MIP-1 beta, and RANTES, have been found to significantly decrease human immunodeficiency virus production from infected T cells. We report here the cloning and characterization of a novel human chemokine termed Exodus for its chemotactic properties. This novel chemokine is distantly related to other chemokines (28% homology with MIP-1 alpha) and shares several biological activities. Exodus is expressed preferentially in lymphocytes and monocytes, and its expression is markedly upregulated by mediators of inflammation such as tumor necrosis factor or lipopolysaccharide. Purified synthetic Exodus was found to inhibit proliferation of myeloid progenitors in colony formation assays. Exodus also stimulated chemotaxis of peripheral blood mononuclear cells. The sequence homology, expression, and biological activity indicate that Exodus represents a novel divergent beta-chemokine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020